A downtrend has been apparent in Artivion (AORT) lately with too much selling pressure. The stock has declined 18.6% over the ...

Medical device company Artivion (NYSE:AORT) in Q4 CY2024 as sales rose 3.9% year on year to $97.31 million. The company’s ...

Artivion Price Performance Shares of NYSE AORT opened at $25.34 on Friday. The company has a current ratio of 1.88, a quick ratio of 1.33 and a debt-to-equity ratio of 0.71. The stock has a fifty ...

Needham lowered the firm’s price target on Artivion (AORT) to $32 from $34 and keeps a Buy rating on the shares after its Q4 results. The ...

Stifel lowered the firm’s price target on Artivion (AORT) to $30 from $33 and keeps a Buy rating on the shares after Q4 consensus sales ...

Artivion (NYSE:AORT – Get Free Report) had its target price reduced by equities research analysts at Stifel Nicolaus from $33 ...

Artivion (AORT) delivered earnings and revenue surprises of -100% and 3.56%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Artivion shares have dropped nearly 3% since the beginning of the year. In the final minutes of trading on Monday, shares hit $27.85, an increase of 41% in the last 12 months.

View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-reports-fourth-quarter-and-full-year-2024-financial-results-302383788 ...

Medical device company Artivion (NYSE:AORT) missed Wall Street’s revenue expectations in Q4 CY2024 as sales rose 3.9% year on year to $97.31 million. The company’s full-year revenue guidance ...

The Kennesaw, Georgia-based company said it had a loss of 39 cents per share. Earnings, adjusted for one-time gains and costs, were less than 1 cent on a per-share basis. The biological medical device ...

KENNESAW, Ga. (AP) — KENNESAW, Ga. (AP) — Artivion, Inc. (AORT) on Monday reported a loss of $16.5 million in its fourth quarter. The Kennesaw, Georgia-based company said it had a loss of 39 ...